ALLT · Insider Trading

Allot Ltd. Ordinary Shares

Every open-market purchase and sale reported by ALLT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
21
most recent
Open-Market Buys
0
code P
Sales
15
code S
Reporting Insiders
11
current holders
ALLT — Recent Form 4 Transactions (latest 2026-11-10)
FiledInsiderRole TypeSharesValue
2026-11-10 Eyal David Harari Chief Executive Officer Sell −28,923 −$257.87K
2026-11-03 Inbar Charash General Counsel Sell −555 −$4.72K
2026-10-26 Efrat Makov Director A +13,512 —
2026-10-26 Steven D Levy Director A +13,512 —
2026-10-26 Nadav Zohar Director A +13,512 —
2026-10-26 Raphael Kesten Director A +13,512 —
2026-10-26 David M Reis Director A +23,768 —
2026-08-31 Boaz Grossman Senior Vice President R&D Sell −4,000 −$31.20K
2026-08-24 Boaz Grossman Senior Vice President R&D Sell −6,000 −$44.70K
2026-08-19 Gili Groner Chief Human Resources Officer Sell −26,666 −$209.55K
2026-08-10 Eyal David Harari Chief Executive Officer Sell −29,111 −$222.38K
2026-08-04 Inbar Charash General Counsel Sell −556 −$4.34K
2026-06-16 Mark Shteiman Chief Product Officer Sell −2,000 −$15.00K
2026-06-02 Noam Lelah SVP Customer Success & Ops Sell −21,000 −$178.08K
2026-05-26 Mark Shteiman Chief Product Officer Sell −11,000 −$82.43K
2026-05-21 Boaz Grossman Senior Vice President R&D Sell −5,000 −$36.85K
2026-05-20 Mark Shteiman Chief Product Officer Sell −5,000 −$36.60K
2026-05-19 Mark Shteiman Chief Product Officer Sell −3,000 −$21.39K
2026-05-13 Eyal David Harari Chief Executive Officer A +72,259 —
2026-05-04 Inbar Charash General Counsel Sell −556 −$4.11K
2007-09-19 Advent PGGM Gemini Limited Partnership 10%+ Owner Sell −509,000 −$3.35M
ALLT — Current Insider Holders
InsiderRole Shares HeldValue
Eyal David Harari Chief Executive Officer 1,099,118 $9.65M
Mark Shteiman Chief Product Officer 212,000 $1.86M
David M Reis Director 185,768 $1.63M
Boaz Grossman Senior Vice President R&D 182,000 $1.60M
Noam Lelah SVP Customer Success & Ops 176,250 $1.55M
Raphael Kesten Director 60,884 $534.56K
Gili Groner Chief Human Resources Officer 59,467 $522.12K
Nadav Zohar Director 58,884 $517.00K
Steven D Levy Director 45,661 $400.90K
Efrat Makov Director 43,198 $379.28K
Inbar Charash General Counsel 27,453 $241.04K
ALLT Insider Trading FAQ
Who are the insiders at ALLT?
11 officers, directors and 10%+ beneficial owners currently report holdings in ALLT via SEC Form 4.
Are ALLT insiders buying or selling?
Across the 21 most recent Form 4 filings for ALLT, 0 were open-market purchases (code P) and 15 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is ALLT insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent ALLT filing is dated 2026-11-10.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the ALLT quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.